细胞凋亡
癌症研究
肺癌
半胱氨酸蛋白酶3
体内
体外
半胱氨酸蛋白酶
蛋白质组学
线粒体
细胞
化学
生物
生物化学
医学
程序性细胞死亡
肿瘤科
基因
生物技术
作者
Jigang Wang,Ming Zhao,Qixin Wang,Tengfei Lu,Piao Luo,Lin Chen,Fei Xia,Huanhuan Pang,Shengnan Shen,Genyang Cheng,Congxin Dai,Yuqing Meng,Tianyu Zhong,Caian Qiu,Jigang Wang
标识
DOI:10.1016/j.biopha.2024.116304
摘要
Glycyrrhetinic acid (GA) shows great efficiency against non-small cell lung cancer (NSCLC), but the detailed mechanism is unclear, which has limited its clinical application. Herein, we investigated the potential targets of GA against NSCLC by activity-based protein profiling (ABPP) technology and the combination of histopathology and proteomics validation. In vitro and in vivo results indicated GA significantly inhibited NSCLC via promotion of peroxiredoxin-6 (Prdx6) and caspase-3 (Casp3)-mediated mitochondrial apoptosis. This original finding will provide theoretical and data support to improve the treatment of NSCLC with the application of GA.
科研通智能强力驱动
Strongly Powered by AbleSci AI